Resistance to neoadjuvant talazoparib in triple-negative breast cancer by BRN2-induced ATR/STAT3 pathways or SHLD2 subclone expansion. (pnas.org)

Authors: Abdulkareem NM … Piwnica-Worms H Journal: PNAS Published: 2026-04-21 DOI: https://doi.org/10.1073/pnas.2513742123